Patient characteristics
| Variable . | RIC . | MAC . | P . |
|---|---|---|---|
| Median age, y (range) | 51 (31-66) | 45 (29-59) | < .001 |
| Sex, no. male | 210 (66) | 123 (63) | .5 |
| Subtype | |||
| IgG | 193 (60) | 124 (63) | .03 |
| IgA | 68 (21) | 28 (14) | |
| LC | 49 (15) | 29 (15) | |
| Other/unknown | 10 (4) | 15 (8) | |
| Stage at diagnosis | |||
| I | 25 (8) | 21 (11) | .1 |
| II | 67 (21) | 52 (26) | |
| III | 203 (64) | 108 (55) | |
| Unknown | 25 (8) | 15 (8) | |
| Renal | |||
| A | 219 (68) | 151 (77) | .5 |
| B | 41 (13) | 23 (12) | |
| Unknown | 61 (19) | 22 (11) | |
| No. of prior treatments | |||
| 0 | 12 (4) | 1 (1) | < .001 |
| 1 | 119 (37) | 110 (56) | |
| 2 | 46 (14) | 39 (20) | |
| 3 | 34 (10) | 34 (17) | |
| Unknown | 109 (34) | 12 (6) | |
| Prior transplantation | |||
| 0 | 75 (23) | 175 (89) | < .001 |
| Tandem* | 73 (23) | 1 (0.5) | |
| 1 | 126 (39) | 17 (9) | |
| 2 | 41 (13) | 3 (2) | |
| 3 | 5 (2) | 0 (0) | |
| Remission no. | |||
| 1st | 114 (36) | 90 (46) | < .001 |
| 2nd | 60 (19) | 11 (6) | |
| More than 2nd | 56 (17) | 53 (27) | |
| SD/PD | 90 (28) | 42 (21) | |
| Response at conditioning | |||
| CR | 41 (13) | 29 (15) | .001 |
| PR | 189 (59) | 125 (63) | |
| SD/PD | 90 (28) | 42 (21) | |
| Variable . | RIC . | MAC . | P . |
|---|---|---|---|
| Median age, y (range) | 51 (31-66) | 45 (29-59) | < .001 |
| Sex, no. male | 210 (66) | 123 (63) | .5 |
| Subtype | |||
| IgG | 193 (60) | 124 (63) | .03 |
| IgA | 68 (21) | 28 (14) | |
| LC | 49 (15) | 29 (15) | |
| Other/unknown | 10 (4) | 15 (8) | |
| Stage at diagnosis | |||
| I | 25 (8) | 21 (11) | .1 |
| II | 67 (21) | 52 (26) | |
| III | 203 (64) | 108 (55) | |
| Unknown | 25 (8) | 15 (8) | |
| Renal | |||
| A | 219 (68) | 151 (77) | .5 |
| B | 41 (13) | 23 (12) | |
| Unknown | 61 (19) | 22 (11) | |
| No. of prior treatments | |||
| 0 | 12 (4) | 1 (1) | < .001 |
| 1 | 119 (37) | 110 (56) | |
| 2 | 46 (14) | 39 (20) | |
| 3 | 34 (10) | 34 (17) | |
| Unknown | 109 (34) | 12 (6) | |
| Prior transplantation | |||
| 0 | 75 (23) | 175 (89) | < .001 |
| Tandem* | 73 (23) | 1 (0.5) | |
| 1 | 126 (39) | 17 (9) | |
| 2 | 41 (13) | 3 (2) | |
| 3 | 5 (2) | 0 (0) | |
| Remission no. | |||
| 1st | 114 (36) | 90 (46) | < .001 |
| 2nd | 60 (19) | 11 (6) | |
| More than 2nd | 56 (17) | 53 (27) | |
| SD/PD | 90 (28) | 42 (21) | |
| Response at conditioning | |||
| CR | 41 (13) | 29 (15) | .001 |
| PR | 189 (59) | 125 (63) | |
| SD/PD | 90 (28) | 42 (21) | |
Values indicate no. of patients (%) unless otherwise indicated.
SD indicates stable disease.
Planned tandem transplantation or allograft less than 6 months after autograft without relapse.